Aeterna Zentaris Names Dr. Richard Sachse as Chief Scientific Officer

By: Benzinga
Aeterna Zentaris. (NASDAQ: AEZS ) today announced the appointment of Richard Sachse, MD, PhD, as Senior Vice President, Chief Scientific Officer. Before joining Aeterna Zentaris, Dr. Sachse was Vice President, Head of Global Translational Medicine at Boehringer Ingelheim. See full press release (c) 2014 Benzinga.com. Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.